TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21769617

Group type: EXPERIMENTAL
Intervention: 10 ml of levobupivacaine twice a day postoperatively via preperitoneal catheter
Number of subjects: 50

Group type: COMPARATOR
Intervention: 10 ml of saline
Number of subjects: 50
Study: 19596659

Group type: EXPERIMENTAL
Intervention: Red blood cell transfusion
Number of subjects: 5532

Group type: COMPARATOR
Intervention: No transfusion (control group)
Number of subjects: 5532
Study: 16522909

Group type: COMPARATOR
Intervention: Methionine intake of 0 mg.kg(‐1).d(‐1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Methionine intake of 5 mg.kg(‐1).d(‐1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Methionine intake of 10 mg.kg(‐1).d(‐1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Methionine intake of 15 mg.kg(‐1).d(‐1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Methionine intake of 25 mg.kg(‐1).d(‐1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Methionine intake of 35 mg.kg(‐1).d(‐1)
Number of subjects: 6
Study: 15236826

Group type: EXPERIMENTAL
Intervention: Placebo beverage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control beverage (nonalcoholic drink)
Number of subjects: 0
Study: 10832517

Group type: EXPERIMENTAL
Intervention: Spatial orientation of lamellar stimuli
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orientation of the plane containing the lamellar stimulus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Arrangement of enantiomorphic elements with respect to their axis of symmetry
Number of subjects: 0
Study: 9335366

Group type: EXPERIMENTAL
Intervention: Recirculation type (RC) blood cardioplegia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single pass type (SP) blood cardioplegia
Number of subjects: 0
Study: 8446549

Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 613
Study: 30113604

Group type: EXPERIMENTAL
Intervention: Test group (veneered abutments)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (unveneered abutments)
Number of subjects: 20
Study: 26613788

Group type: EXPERIMENTAL
Intervention: Fitmore short stem
Number of subjects: 144

Group type: COMPARATOR
Intervention: Cementless straight stem
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Both groups (short and straight stem)
Number of subjects: 144
Study: 23884718

Group type: EXPERIMENTAL
Intervention: 125 mL/h intravenously with limited oral intake
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: 250 mL/h intravenously with limited oral intake
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: 25 mL/h intravenously with ad libitum oral intake of clear liquids
Number of subjects: 311
Study: 22386286

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon angioplasty
Number of subjects: 110

Group type: COMPARATOR
Intervention: Uncoated balloon angioplasty
Number of subjects: 110
Study: 19524265

Group type: EXPERIMENTAL
Intervention: Gastrografin (100 mL administered through a nasogastric tube)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no gastrografin)
Number of subjects: 110
Study: 18391715

Group type: COMPARATOR
Intervention: Normal population (control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Isthmic spondylolisthesis (IS) population
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Comparison of FJO between groups
Number of subjects: 60
Study: 16316567

Group type: EXPERIMENTAL
Intervention: Ferrous L-threonate plus placebo ferrous succinate
Number of subjects: 140

Group type: COMPARATOR
Intervention: Ferrous succinate plus placebo ferrous L-threonate
Number of subjects: 140
Study: 12032434

Group type: EXPERIMENTAL
Intervention: 1-week triple therapy (proton pump inhibitor, amoxicillin 1 g twice daily, clarithromycin 500 mg twice daily)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: 10-day triple therapy (proton pump inhibitor, amoxicillin 1 g twice daily, clarithromycin 500 mg twice daily)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: 14-day triple therapy (proton pump inhibitor, amoxicillin 1 g twice daily, clarithromycin 500 mg twice daily)
Number of subjects: 172
Study: 10472211

Group type: EXPERIMENTAL
Intervention: Ringer's solution 25 ml kg‐1 infused over 15 min
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ringer's solution 25 ml kg‐1 infused over 30 min
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ringer's solution 25 ml kg‐1 infused over 15 min and 30 min
Number of subjects: 10
Study: 7805928

Group type: EXPERIMENTAL
Intervention: Recombinant hFSH
Number of subjects: 123

Group type: COMPARATOR
Intervention: Urinary hFSH
Number of subjects: 123
Study: 1928007

Group type: EXPERIMENTAL
Intervention: 10 micrograms/d (400 IU/d) of vitamin D
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: 20 micrograms/d (800 IU/d) of vitamin D
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: 1.5 micrograms/d of 25-hydroxyvitamin D3
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: 0.85 micrograms/d of 25-hydroxyvitamin D3
Number of subjects: 52
Study: 6137236

Group type: EXPERIMENTAL
Intervention: DAN 2%
Number of subjects: 8

Group type: COMPARATOR
Intervention: Timolol 0.5%
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: DAN 0.5%
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nadolol 2%
Number of subjects: 8
Study: 31472419

Group type: EXPERIMENTAL
Intervention: Virtual house calls (VHCs)
Number of subjects: 36
Study: 30384438

Group type: EXPERIMENTAL
Intervention: AboBoNT‐A (Dysport) injections (400 U) into the adductor muscles
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 46
Study: 26732111

Group type: EXPERIMENTAL
Intervention: Various surgical techniques for varicocele correction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 24881631

Group type: EXPERIMENTAL
Intervention: Ibrutinib
Number of subjects: 391

Group type: COMPARATOR
Intervention: Ofatumumab
Number of subjects: 391
Study: 22267183

Group type: EXPERIMENTAL
Intervention: Fluoxetine treatment (8 weeks)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Healthy comparison subjects (N=21)
Number of subjects: 19
Study: 21152458

Group type: EXPERIMENTAL
Intervention: Patient education (counselling and written instructions)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (clear liquid diet and 4 L of bowel preparation without additional education)
Number of subjects: 38
Study: 17927832

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: DTSQc
Number of subjects: 351

Group type: COMPARATOR
Intervention: DTSQs
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Perceived Hyper- and Hypoglycaemia
Number of subjects: 351
Study: 15020520

Group type: EXPERIMENTAL
Intervention: Pinacidil 25 mg
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Glibenclamide 10.5 mg
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 11910715

Group type: EXPERIMENTAL
Intervention: Oral rehydration solution (ORS) ad libitum (AL group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Oral rehydration solution (ORS) in fractionated doses (FD group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Comparison of ORS intake, rehydration time, and mean diuresis values
Number of subjects: 80
Study: 9824019

Group type: EXPERIMENTAL
Intervention: Humid‐Vent Filter Light HMEF
Number of subjects: 136

Group type: COMPARATOR
Intervention: Pall BB 100 HMEF
Number of subjects: 136
Study: 8131020

Group type: EXPERIMENTAL
Intervention: Local pathology
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Review pathology
Number of subjects: 0
Study: 2782271

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 22
Study: 1097866

Group type: EXPERIMENTAL
Intervention: Soya bean milk (150 ml second-hourly from 7 a.m. to 11 p.m. daily for two weeks)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no soya bean milk therapy)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Soya bean milk
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10
Study: 31287135

Group type: EXPERIMENTAL
Intervention: Awareness of spina bifida among mothers
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Use of medications during pregnancy
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Exposure to imaging radiation during pregnancy
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Experience of moderate to high grade fever during pregnancy
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Folic acid intake before and during pregnancy
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Family history of spina bifida
Number of subjects: 38
Study: 29171489

Group type: EXPERIMENTAL
Intervention: Melatonin with glucosamine hydrochloride and chondroitin sulfate
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Melatonin with glucosamine hydrochloride, chondroitin sulfate, and diclofenac
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Melatonin with diclofenac
Number of subjects: 178
Study: 26011193

Group type: EXPERIMENTAL
Intervention: Acoustic radiation force impulse (ARFI) imaging
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (normal findings)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ARFI imaging
Number of subjects: 30
Study: 24552970

Group type: EXPERIMENTAL
Intervention: Interactive iPad-based informational program (IPI)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Standard institutional verbal and written information (SI)
Number of subjects: 151
Study: 22084157

Group type: EXPERIMENTAL
Intervention: Lensectomy and anterior vitrectomy
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Intraocular lens implant
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Overall treated eye
Number of subjects: 114
Study: 20351873

Group type: EXPERIMENTAL
Intervention: Interactive self-care framework
Number of subjects: 0
Study: 17466473

Group type: EXPERIMENTAL
Intervention: Intervention group (4 sessions of instructions on preterm infant behavior for 2 weeks)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no instructions)
Number of subjects: 22
Study: 15892277

Group type: EXPERIMENTAL
Intervention: Activating blood circulation to remove blood stasis recipe (ARR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional western medicine
Number of subjects: 60
Study: 11974451

Group type: EXPERIMENTAL
Intervention: Canine-and-canine retainer
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 0.0195" canine-to-canine retainer
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 0.0215" canine-to-canine retainer
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Dry field bonding
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Relatively dry field bonding
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Heliosit composite
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Concise composite
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: All retainer types
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Canine-and-canine retainers
Number of subjects: 103
Study: 10438343

Group type: EXPERIMENTAL
Intervention: Intravenous zanamivir (600 mg 2x/day for 5 days)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 7782954

Group type: EXPERIMENTAL
Intervention: Kangaroo care for 4 hours a day, 6 days a week, for 3 weeks
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Kangaroo care
Number of subjects: 8

Group type: COMPARATOR
Intervention: Incubator care
Number of subjects: 8
Study: 1981880

Group type: EXPERIMENTAL
Intervention: Reduced glutathione supplementation
Number of subjects: 0
Study: 7006273

Group type: EXPERIMENTAL
Intervention: Oestradiol
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Norephedrine in combination with oestradiol
Number of subjects: 13

Group type: COMPARATOR
Intervention: Norephedrine alone
Number of subjects: 13
Study: 30988147

Group type: EXPERIMENTAL
Intervention: Double-lactam combination therapy (DBL)
Number of subjects: 2771

Group type: COMPARATOR
Intervention: -lactam plus aminoglycoside combinations (BLAG)
Number of subjects: 2771
Study: 29262823

Group type: EXPERIMENTAL
Intervention: mHealth intervention (interactive mobile phone quiz with phone credit rewards for correct answers)
Number of subjects: 0
Study: 25358636

Group type: EXPERIMENTAL
Intervention: Robotic training alone (Group A)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Robotic training with Botulinum toxin neurolysis (Group B)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Both groups (Group A and Group B)
Number of subjects: 15
Study: 23503651

Group type: EXPERIMENTAL
Intervention: Poor oral hygiene (brushing teeth less than daily)
Number of subjects: 922

Group type: EXPERIMENTAL
Intervention: Tooth loss and DMFT score
Number of subjects: 922
Study: 21679925

Group type: EXPERIMENTAL
Intervention: Transdiagnostic internet cognitive behavioral therapy (iCBT) program consisting of online educational lessons, homework assignments, weekly contact from a clinical psychologist, access to an online forum, and automated emails.
Number of subjects: 77

Group type: COMPARATOR
Intervention: Waitlist Control group
Number of subjects: 77
Study: 19139033

Group type: EXPERIMENTAL
Intervention: Regular exercise (three times/week) during the second and third trimester
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 160
Study: 16404361

Group type: EXPERIMENTAL
Intervention: Docetaxel 100 mg m(‐2) (day 1) (arm A)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Docetaxel 75 mg m(‐2) (day 8) and gemcitabine 1250 mg m(‐2) (days 1,8) (arm B)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Docetaxel 25 mg m(‐2) and gemcitabine 800 mg m(‐2) (both given weekly (days 1,8,15)) (arm C)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Carboplatin AUC 7 followed by docetaxel-based therapy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Gemcitabine-containing arms (arm B and arm C)
Number of subjects: 44
Study: 15042003

Group type: EXPERIMENTAL
Intervention: Cell-free fetal DNA (cffDNA) measured before and after preeclampsia
Number of subjects: 120

Group type: COMPARATOR
Intervention: Cell-free fetal DNA (cffDNA) measured before preeclampsia
Number of subjects: 120

Group type: COMPARATOR
Intervention: Cell-free fetal DNA (cffDNA) measured within 3 weeks before preeclampsia
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) serum concentrations
Number of subjects: 120
Study: 10539396

Group type: EXPERIMENTAL
Intervention: Riluzole
Number of subjects: 633

Group type: COMPARATOR
Intervention: Usual care without riluzole (Placebo)
Number of subjects: 633
Study: 7793191

Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combination of Atracurium and Vecuronium (cAV)
Number of subjects: 45
Study: 2111252

Group type: EXPERIMENTAL
Intervention: AA-861
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7238995

Group type: EXPERIMENTAL
Intervention: Ticlopidine
Number of subjects: 46

Group type: COMPARATOR
Intervention: Acenocoumarol
Number of subjects: 46
Study: 31508730

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (2 hours)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 14
Study: 28459941

Group type: EXPERIMENTAL
Intervention: iddEPC regimen (E 150 mg/m2, P 225 mg/m2, C 2500 mg/m2, reduced to 2000 mg/m2 after 1200 patients) q2w i.v.
Number of subjects: 2994

Group type: COMPARATOR
Intervention: ddEC-PwX regimen (E 112.5 mg/m2 + C 600 mg/m2 i.v. q2w for 4 cycles, followed by Pw 67.5 mg/m2 i.v. q8d for 10 weeks + X 2000 mg/m2 p.o. days 1-14, q22 for 4 cycles)
Number of subjects: 2994
Study: 24355670

Group type: EXPERIMENTAL
Intervention: Daily Challenge (multimodal e-mail, web, and mobile-based intervention)
Number of subjects: 1503

Group type: COMPARATOR
Intervention: Traditional weekly health newsletter (control)
Number of subjects: 1503
Study: 21880070

Group type: EXPERIMENTAL
Intervention: Retrograde arterial flush (RGAF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-RGAF (portal flush only)
Number of subjects: 0
Study: 20518171

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS) combined with auricular acupoint sticking (AAS), treated once each day for 15 days, with 3 courses of treatment evaluated after 45 days.
Number of subjects: 250

Group type: COMPARATOR
Intervention: Desmopressin Acetate (DA) and Meclofenoxate, treated for 2 months.
Number of subjects: 250
Study: 17335683

Group type: EXPERIMENTAL
Intervention: Chemotherapy and radiation therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment algorithms based on published data and clinical experience
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical research protocols
Number of subjects: 0
Study: 15290001

Group type: EXPERIMENTAL
Intervention: 0.8 g/kg ethanol
Number of subjects: 11

Group type: COMPARATOR
Intervention: juice (placebo)
Number of subjects: 11
Study: 12403892

Group type: EXPERIMENTAL
Intervention: FFR-PTCA group (37 lesions with FFR >= 0.94 after PTCA)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: FFR-stent group (40 lesions with FFR < 0.94)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group (stent-only group, 78 lesions)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: FFR-guided patients (combined FFR-PTCA and FFR-stent)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group (stent-only group)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: FFR-guided patients
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: FFR-guided patients and control group
Number of subjects: 155
Study: 9919645

Group type: EXPERIMENTAL
Intervention: Multimodal inservice training program for foster parents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Future foster parent training efforts
Number of subjects: 0
Study: 7585311

Group type: EXPERIMENTAL
Intervention: Otago photoscreener
Number of subjects: 1245

Group type: COMPARATOR
Intervention: Manual technique
Number of subjects: 1245
Study: 2105673

Group type: EXPERIMENTAL
Intervention: 6 mg naltrexone
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 9 mg naltrexone
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 7262174

Group type: EXPERIMENTAL
Intervention: Commercial capsule containing 50 mg of ketoprofen
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Simple capsule containing 50 mg of ketoprofen
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Commercial capsule taken 6 hourly for thirteen doses
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ketoprofen solution
Number of subjects: 12

Group type: COMPARATOR
Intervention: Commercial capsule
Number of subjects: 12

Group type: COMPARATOR
Intervention: Simple capsule
Number of subjects: 12
Study: 30823946

Group type: EXPERIMENTAL
Intervention: Ultrasound debridement technique
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional surgical debridement
Number of subjects: 80
Study: 28041747

Group type: EXPERIMENTAL
Intervention: Autologous fat graft
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 8
Study: 27556313

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (routine management)
Number of subjects: 50
Study: 25109244

Group type: EXPERIMENTAL
Intervention: 5-aminolaevulinic acid nanoemulsion (BF-200 ALA)
Number of subjects: 13

Group type: COMPARATOR
Intervention: methyl-5-aminolaevulinate (MAL)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: BF-200 ALA
Number of subjects: 13

Group type: COMPARATOR
Intervention: MAL
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: BF-200 ALA and MAL
Number of subjects: 13
Study: 23063820

Group type: EXPERIMENTAL
Intervention: IVF
Number of subjects: 8

Group type: COMPARATOR
Intervention: ICSI
Number of subjects: 8
Study: 19652072

Group type: EXPERIMENTAL
Intervention: Sunitinib 37.5 mg/d (AM dosing)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Sunitinib 37.5 mg/d (PM dosing)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Sunitinib 37.5 mg/d
Number of subjects: 107
Study: 17280919

Group type: EXPERIMENTAL
Intervention: Imagine-patient perspective-taking
Number of subjects: 126

Group type: COMPARATOR
Intervention: Imagine-self perspective-taking
Number of subjects: 126

Group type: COMPARATOR
Intervention: Neutral condition
Number of subjects: 126
Study: 17144773

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 0
Study: 15286420

Group type: EXPERIMENTAL
Intervention: Classroom-based education program on heart function, nutrition, and exercise for healthy heart and living tobacco free, presented for 2 hours per week over 8 weeks.
Number of subjects: 1128

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 1128
Study: 10771234

Group type: EXPERIMENTAL
Intervention: 3‐piece silicone multifocal IOL
Number of subjects: 20

Group type: COMPARATOR
Intervention: 3‐piece acrylic IOL
Number of subjects: 20
Study: 8653998

Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2b (2 or 10 MU/m2/day SQ for 3 days) before etoposide
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2b (2 or 10 MU/m2/day SQ for 3 days) concurrent with etoposide
Number of subjects: 29

Group type: COMPARATOR
Intervention: Etoposide (75, 100, or 125 mg/m2/day)
Number of subjects: 29
Study: 1735659

Group type: EXPERIMENTAL
Intervention: Graded compression support hose
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 56
Study: 6299093

Group type: EXPERIMENTAL
Intervention: m-AMSA 120 mg/m2 intravenously every 3 weeks
Number of subjects: 89

Group type: COMPARATOR
Intervention: neocarzinostatin 2.0 mg/m2 intravenously daily X 5 every 4 weeks
Number of subjects: 89
Study: 30829505

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy integrated with motivational interviewing
Number of subjects: 85
Study: 27819755

Group type: EXPERIMENTAL
Intervention: PCSD (novel penile circumcision suturing device)
Number of subjects: 124

Group type: COMPARATOR
Intervention: SR (Shang ring)
Number of subjects: 124
Study: 26905786

Group type: EXPERIMENTAL
Intervention: Ortho-k lenses
Number of subjects: 78

Group type: COMPARATOR
Intervention: Single-vision spectacles (control)
Number of subjects: 78